Chinese Journal of Cancer 2001 Issue 4 fei qing chu xing yi ji yin wai zhou zao xue gan xi bao yi zhi zhi liao nan zhi xing ji xing bai xue bing 1 li

fei qing chu xing yi ji yin wai zhou zao xue gan xi bao yi zhi zhi liao nan zhi xing ji xing bai xue bing 1 li
qiao jian hui ; ai hui sheng ; yu chang lin ; wang dan hong ; guo mei ; zhang shi ; zuo huai zuo

..............page:448

yun nan bai yao san wai fu zhi liao hua liao yao jing mai shen lou 20 li bao gao
zheng dan miao ; he dan dan ; li li rong ; liu yu qin ; zhu jie mei ; zhang da mei

..............page:447

gan xi bao yi zhi zhi chi xia de gao ji liang hua liao zai xiao xi bao fei ai zhong de ying yong
cheng gang ; chen yan ; zhou mei zhen

..............page:444-446

nao jiao zhi liu de zong he zhi liao
chen zhong ping

..............page:441-443

you bing ya an dui zuo huan lei kang zhong liu kang sheng su xin zang bao hu zuo yong de yan jiu jin zhan
zhao xian ying ; liu yi min ; zhang tao

..............page:439-440

hsp70 zai luan chao ai zhong de biao da yu hua liao nai yao he yu hou de guan xi
li lin ; chen hui zuo ; hu kun

..............page:437-438

fk yu fep fang an zhi liao e xing zi yang xi bao liu de dui bi fen xi
lu yu lin ; wang yan hong ; liu tong ; tang yao shan

..............page:436

yi huan lin zuo an zhi liao tou jing bu ruan zu zhi rou liu de liao xiao guan cha
zhu you hua ; sun xue hua ; deng wan kai

..............page:435

zi shan chun zhi liao nan zhi xing luan chao shang pi xing ai
li yan fang ; li meng da ; liu fu yuan ; liu ji hong ; li jun dong ; huang yong yi

..............page:433-434

ru xian ai gu zhuan yi zong he zhi liao de tan tao fu 48 li lin chuang bao gao
tao ping ; fan an yin ; zhang qin ; gou hou yi ; xu rong sheng

..............page:431-432

Pericardial Effusion in Patients with Lung Cancer Treated with Safe-Dwel Plus Drain and Intrapericardial Chemotherapy
GAO Feng;LI Qiu-yan;SUN Jian-guo;FU Shou-zhong;WANG Jun-feng

..............page:429-430

Study of High Dose Oral Tamoxifen Using a Potential Multidrug-Resistance-Reversal Agent in Refractory Patients with Non-Small Cell Lung Cancer
JIANG Qin;ZHANG Wei-min;ZHAN Mao-cheng;JI Ya-jun;XU Guang-hui;BIAN Bao-xiang

..............page:426-428

Bronchial Arterial Infusion of Chemotherapeutic Drugs in Treatment of Patients with Locally Advanced Non-Small Cell Lung Cancer
CAI Xiao-ling;CAO Xiao-long;JIANG Bing-fen;GUO Tian-sheng

..............page:423-425

Phase Ⅱ Clinical Study of Topotecan in Treatment of Patients with Small Cell Lung Cancer： A Multiple Center Clinical Trail
ZHANG Li;XIA Zhong-Jun;GUAN Zhong-Zhen;LI Pei-wen;Liu You-ning;HU Xiao-dian;ZHOU Qing-hua;NI Dian-tao;WANG Xue-Lan

..............page:419-422

Concomitant Cisplatin and 5-Fluorouracil with Veinal or with Oral High-Dose Leucovorin in Treatment of Patients with Advanced Nasopharygeal Carcinoma
LI Ping;ZHENG Jian;GUO Liang-jun;ZHUANG Cheng-hai

..............page:415-418

Evaluation of Four Regimens for Treatment of Patients with Late Nasopharyngeal Carcinoma
YIN Xian-li;LI Jin;WANG Ping-hei

..............page:412-414

Randomized Clinical Trial of Chemotherapy Combined with Radiotherapy for Advanced Nasopharyngeal Carcinoma
LUO Mei-hua;QIN Qiang;WEN E-luo;GAO Shi-rong;PAN Luo;YANG Guang-wei;Chen Jie

..............page:409-411

Prognostic Value of Serum β2-Microglobulin Level in Patients with Non-Hodgkin′s Lymphoma
XIA Zhong-Jun;HUANG Ren-wei;WU Xiang-Yuan;LIN Gui-zhen;ZHANG Li;GUAN Zhong-Zhen

..............page:406-408

Comparing CVDLP with CHOP in Induction Treatment for Patients with Advanced Lymphoblastic Lymphoma
SUN Xiao-fei;GUAN Zhong-Zhen;ZHOU Zhong-mei;ZHANG Li;LI Yu-hong;XIA Zhong-Jun;HUANG He;HUANG Hui-Qiang;HE You-Jian;CHEN Li-kun;CHEN Ru-qin;TIAN Wei-hua

..............page:403-405

Autologous Hematopoietic Stem Cell Transplantation for Hematological Malignancies and Solid Tumors
Sun Zhi-xin;CHEN Lin-jun;MA Jun;CHEN Wen-yi;ZONG Pei;CAO Jing

..............page:399-402

Advanced and Recurrent Malignant Lymphoma Were Treated by BEAC Regimen Supported with Autologous Hemotopoietic Stem Cells Transplantation
HUANG Hui-Qiang;GUAN Zhong-Zhen;HE You-jiang;JIANG Wen-Qi;SUN Xiao-fei;LIU Dong-geng;XU Rui-Hua;ZHANG Li;ZHOU Zhong-mei;LIN Tong-Yu;Li Yu-hong

..............page:394-398

Effects of Matrine on hTERT-mRNA Expression and Telomerase Activity in K562 Cells
LI Xu-fen;ZHANG Su-zhan;ZHENG Shu;ZHANG Xing

..............page:391-393

Comparison of mdr1, ERCC2,and MGMT Expression in Human Glioma
WANG Ai-dong;HUANG Qiang;LUO Liang-sheng;CHEN Zhong-ping

..............page:387-390

Preliminary Study on Conquering Multidrug Resistance with Exogenous TNF-α Gene Therapy
GUO Wei-jian;QIAN Guan-xiang;HU Liang;SUN Yu-xiao;SHEN Zhao-zhong;LUO Jian-ming;ZHENG Song-guo

..............page:383-386

Significance of Multidrug Resistance-Associated Protein Gene and P-gp Expression in Malignant Lymphomas
YANG Xi-gui;WEI Ling;SONG Shu-ping;JIA Li-ya

..............page:379-382

Inhibition of Multidrug Resistance in Human Tumor Cell by Naphthyl Imide-Conjugated Antisense Oligonucleotide
LI Jun-sheng;WEI Dong-zhi;ZHOU Yu-xun;QIAN Jian-chao;ZHU Dong-hui;ZHANG Yuan-xing

..............page:373-378

QSAR Study of Podophyllotoxin Derivatives as Potential Antitumor Drugs
HE Feng;LUO Yi-fan;CHENG Zhi-yi;LIU Zong-Chao;LI Zhi-ming;XIE Bing-feng;FENG Gong-kan;ZHU Xiao-feng

..............page:368-372

Study of Anticancer Effect of Hydroxycampothecin-based Combination against Experimental Nasopharyngeal Carcinoma
FU Li-Wu;LIANG Yong-Ju;PAN Qi-chao

..............page:363-367

Tea Polyphenols Down Regulated Expression of Cyclin D1 in Nasopharyngeal Carcinoma Cells
LUO Fei-jun;Hu Zhi;ZHAO Xiao-rong;DENG Xi-yun;YI Wei;GU Huan-hua;CAO Ya

..............page:358-362

Initial Evaluation of mdm2 Inhibitors Based on p53-mdm2 Complex Structure
ZHAO Jian-hua;LIU Zhi-hua;LUO Ai-ping;WU Min;YIN Da-li;CHEN Jie

..............page:354-357

Suppression Subtractive Hybridization Identified Genes Differentially Expressed in a Multidrug Resistance Cell Line of Human Lung Adenocarcinoma
CHEN Jie;QIAN Gui-sheng;HUANG Gui-jun;XIONG Wei;LI Jing

..............page:348-353

Discovery of HER2/neu Tyrosine Kinase Inhibitor through Computer-Aided Drug Design Approach and its Biological Activity
ZHU Xiao-Feng;ZENG Yi-xin;YANG Da-jun

..............page:341-347